SEC Company Response from Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Oct 31, 2014
Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: Oct. 31, 2014 · CIK: 0001585608 · Accession: 0001104659-14-075636
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-198383
Letter
Re: Jaguar Animal Health, Inc.
October 31, 2014
Via E-mail and EDGAR Submission
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeffrey P. Riedler, Assistant Director
Registration Statement Filed on Form S-1
Registration Number 333-198383
Ladies and Gentlemen:
In connection with the above-referenced Registration Statement on Form S-1, and pursuant to Rule 461 under the Securities Act of 1933, as amended, as representatives for the several underwriters in the offering of shares of common stock of Jaguar Animal Health, Inc. (the “Company”), pursuant to such Registration Statement (the “Offering”), we hereby join the Company in requesting that the effective date for such Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., Eastern Standard Time, on November 4, 2014, or as soon thereafter as practicable.
We wish to advise you that October 28, 2014 through the date hereof, the participating underwriters have distributed 472 copies of the preliminary prospectus dated October 28, 2014 (the “Preliminary Prospectus”) as follows: 439 to institutional investors and 33 to prospective underwriters, dealers, individuals and others.
We confirm that the underwriters participating in the Offering are aware of their obligations under Rule 15c2-8 of the Securities Exchange Act of 1934, as amended.
(Signature Page Follows)
Very truly yours,
BMO CAPITAL MARKETS CORP.
Show Raw Text
CORRESP 1 filename1.htm October 31, 2014 Via E-mail and EDGAR Submission U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Jeffrey P. Riedler, Assistant Director Re: Jaguar Animal Health, Inc. Registration Statement Filed on Form S-1 Registration Number 333-198383 Ladies and Gentlemen: In connection with the above-referenced Registration Statement on Form S-1, and pursuant to Rule 461 under the Securities Act of 1933, as amended, as representatives for the several underwriters in the offering of shares of common stock of Jaguar Animal Health, Inc. (the “Company”), pursuant to such Registration Statement (the “Offering”), we hereby join the Company in requesting that the effective date for such Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., Eastern Standard Time, on November 4, 2014, or as soon thereafter as practicable. We wish to advise you that October 28, 2014 through the date hereof, the participating underwriters have distributed 472 copies of the preliminary prospectus dated October 28, 2014 (the “Preliminary Prospectus”) as follows: 439 to institutional investors and 33 to prospective underwriters, dealers, individuals and others. We confirm that the underwriters participating in the Offering are aware of their obligations under Rule 15c2-8 of the Securities Exchange Act of 1934, as amended. (Signature Page Follows) Very truly yours, BMO CAPITAL MARKETS CORP. GUGGENHEIM SECURITIES, LLC As representatives of the several underwriters BMO CAPITAL MARKETS CORP. By: /s/ Pritesh Shah Name: Pritesh Shah Title: Vice President GUGGENHEIM SECURITIES, LLC By: /S/ Ron Iervolino Name: Ron Iervolino Title: Senior Managing Director [SIGNATURE PAGE TO ACCELERATION REQUEST OF THE UNDERWRITERS]